
XTL Biopharmaceuticals Ltd. XTLB
€ 0.69
4.35%
Geschäftsbericht 2024
hinzugefügt 21.02.2026
XTL Biopharmaceuticals Ltd. EBITDA per Share 2011-2026 | XTLB
EBITDA per Share Jährlich XTL Biopharmaceuticals Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -0.18 | -0.16 | -0.15 | -0.27 | -0.624 | -0.755 | -0.871 | -0.986 | -1.08 | -0.566 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.15 | -1.08 | -0.564 |
EBITDA per Share anderer Aktien in der Pharmaeinzelhändler
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Apellis Pharmaceuticals
APLS
|
0.45 | $ 20.29 | -1.98 % | $ 2.56 B | ||
|
Aptorum Group Limited
APM
|
0.34 | $ 0.8 | -5.3 % | $ 4.36 M | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Axsome Therapeutics
AXSM
|
-3.34 | $ 166.0 | -0.23 % | $ 8.26 B | ||
|
AbCellera Biologics
ABCL
|
-0.67 | $ 3.74 | -2.23 % | $ 1.12 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 8.59 | -1.66 % | $ 1.4 B | ||
|
Certara
CERT
|
0.6 | $ 7.22 | 2.34 % | $ 1.16 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
2.11 | $ 23.78 | -0.42 % | $ 2.91 B | ||
|
Corvus Pharmaceuticals
CRVS
|
-0.48 | $ 18.17 | 1.57 % | $ 873 M | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
ARCA biopharma
ABIO
|
-5.25 | - | 1052.0 % | $ 415 M | ||
|
Eton Pharmaceuticals
ETON
|
-0.01 | $ 17.9 | -1.38 % | $ 459 M | ||
|
Exelixis
EXEL
|
3.32 | $ 40.5 | -1.29 % | $ 11 B | ||
|
Acer Therapeutics
ACER
|
-1.56 | - | 2.71 % | $ 14 M | ||
|
Alpine Immune Sciences
ALPN
|
-1.72 | - | - | $ 2.17 B | ||
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Galectin Therapeutics
GALT
|
-0.52 | $ 2.89 | -5.56 % | $ 180 M | ||
|
Capricor Therapeutics
CAPR
|
-0.86 | $ 26.3 | -2.08 % | $ 704 M | ||
|
Acasti Pharma
ACST
|
-1.38 | - | 4.01 % | $ 150 M | ||
|
Codexis
CDXS
|
-0.73 | $ 1.02 | -0.33 % | $ 74.9 M | ||
|
Galapagos NV
GLPG
|
-2.53 | $ 33.13 | -2.82 % | $ 2.69 B | ||
|
Greenwich LifeSciences
GLSI
|
-1.23 | $ 27.88 | 1.79 % | $ 363 M | ||
|
Galecto
GLTO
|
-1.49 | $ 29.63 | -1.41 % | $ 787 M | ||
|
Genmab A/S
GMAB
|
10.4 | $ 27.66 | -6.71 % | $ 17.7 B | ||
|
Halozyme Therapeutics
HALO
|
4.01 | $ 68.58 | -1.82 % | $ 8.22 B | ||
|
CureVac N.V.
CVAC
|
-2.22 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
Hoth Therapeutics
HOTH
|
-1.29 | $ 1.0 | -1.47 % | $ 6.38 M | ||
|
AgeX Therapeutics
AGE
|
-9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Harmony Biosciences Holdings
HRMY
|
4.04 | $ 28.32 | -2.01 % | $ 1.63 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
ImmuCell Corporation
ICCC
|
0.13 | $ 6.3 | -3.67 % | $ 51.5 M | ||
|
AIkido Pharma
AIKI
|
-1.85 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
-408 | $ 3.27 | -2.1 % | $ 1.17 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B | ||
|
Agios Pharmaceuticals
AGIO
|
-8.05 | $ 28.57 | -2.16 % | $ 1.66 B | ||
|
Immatics N.V.
IMTX
|
-1.37 | $ 10.09 | 1.0 % | $ 635 M | ||
|
Immunic
IMUX
|
-0.66 | $ 1.13 | 6.61 % | $ 176 M | ||
|
Immunovant
IMVT
|
0.000741 | $ 27.09 | -2.38 % | $ 4.11 B | ||
|
Inhibrx
INBX
|
-4.63 | $ 76.39 | -1.42 % | $ 3.6 B | ||
|
InMed Pharmaceuticals
INM
|
-3.16 | $ 0.8 | -2.44 % | $ 1.96 M |